FDA approves Elite supplemental application for naltrexone tablets
Naltrexone, an opioid receptor antagonist, is used primarily to manage alcohol dependence and opioid addiction. The approval will allow Elite to begin the commercial manufacturing and packaging of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.